Suppression Of Radiation Induced Pulmonary Metastasis By Yc-1 Through Inhibition Of Cancer Cell Invasion And Adhesion Capabilities In A Mouse Model
J. Cheng,C. Chou,B. Ho,S. Kuo,F. Lee,C. Teng
DOI: https://doi.org/10.1016/j.ijrobp.2005.07.808
2005-01-01
Abstract:Purpose/Objective: Metastasis has been the lethal factor in cancer patients. YC-1, 3-(5′-hydroxymethyl-2′-furyl)-1-benzylindazole, an agent developed for circulatory disorders by inhibiting platelet aggregation and vascular contraction, was found to inhibit hypoxia inducible factor-1 (HIF-1) activity. HIF-1 is a stress protein during radiation and modulates genes associated with cancer invasion and metastasis. With HIF-1 as a molecular target of YC-1, we try to clarify the therapeutic effect and mechanism of YC-1 on radiation induced cancer metastasis.Materials/Methods: An established animal model with radiation induced pulmonary metastasis was used in this study. The right thighs of thirty-two C57BL/6 mice were injected subcutaneously with 1 × 106 Lewis lung carcinoma (LLC-LM) cells. Animals were randomized to one of the four groups, including no treatment (Control), radiation with 50 Gy in five 10 Gy daily fractions (RT), radiation with 50 Gy in five 10 Gy daily fractions and YC-1 (RT+YC-1), and YC-1 alone (YC-1). Radiation with cobalt-60 started 7 days after LLC-LM cell implantation. YC-1 (10mg/kg/day) was given orally from 3 days before radiation to the last day of the study. The animals were sacrificed 14 days after radiation. The serial sections of both lungs in each mouse were taken for the number of pulmonary metastasis. Besides, LLC-LM cells were in vitro treated with 5 to 20 uM of YC-1 for cytotoxicity test in MTT assay, with non-toxic dose of YC-1 used in the subsequent adhesion and invasion assay. Metalloprotease (MMP)-2 activities were determined by gelatin zymography assay and RT-PCR. Level of focal adhesion kinase (FAK) phosphorylation was determined by western blot.Results: The eradication of a primary LLC-LM was followed by the rapid growth of pulmonary metastasis within 14 days after radiation. Radiation to the thigh tumor induced pulmonary metastasis significantly (Control vs. RT, p<0.001). Pulmonary metastases was significantly reduced with the addition of YC-1 to radiation (RT vs. RT+YC-1, p<0.001). YC-1 itself did not have any impact on pulmonary metastasis (Control vs. YC-1, p=0.883). The body weight of mice with radiation alone was lower than the other groups, but the difference was not statistically significant. The gelatin zymography with mouse urine samples showed that the level of MMP-2 activity, correlated with tumor growth, was much lower in YC-1 treated groups. The in vitro study showed YC-1 significantly inhibited radiation induced LLC-LM cell invasion on matrigel coated Boyden chamber, MMP-2 expression, and serum induced FAK phosphorylation. Purpose/Objective: Metastasis has been the lethal factor in cancer patients. YC-1, 3-(5′-hydroxymethyl-2′-furyl)-1-benzylindazole, an agent developed for circulatory disorders by inhibiting platelet aggregation and vascular contraction, was found to inhibit hypoxia inducible factor-1 (HIF-1) activity. HIF-1 is a stress protein during radiation and modulates genes associated with cancer invasion and metastasis. With HIF-1 as a molecular target of YC-1, we try to clarify the therapeutic effect and mechanism of YC-1 on radiation induced cancer metastasis. Materials/Methods: An established animal model with radiation induced pulmonary metastasis was used in this study. The right thighs of thirty-two C57BL/6 mice were injected subcutaneously with 1 × 106 Lewis lung carcinoma (LLC-LM) cells. Animals were randomized to one of the four groups, including no treatment (Control), radiation with 50 Gy in five 10 Gy daily fractions (RT), radiation with 50 Gy in five 10 Gy daily fractions and YC-1 (RT+YC-1), and YC-1 alone (YC-1). Radiation with cobalt-60 started 7 days after LLC-LM cell implantation. YC-1 (10mg/kg/day) was given orally from 3 days before radiation to the last day of the study. The animals were sacrificed 14 days after radiation. The serial sections of both lungs in each mouse were taken for the number of pulmonary metastasis. Besides, LLC-LM cells were in vitro treated with 5 to 20 uM of YC-1 for cytotoxicity test in MTT assay, with non-toxic dose of YC-1 used in the subsequent adhesion and invasion assay. Metalloprotease (MMP)-2 activities were determined by gelatin zymography assay and RT-PCR. Level of focal adhesion kinase (FAK) phosphorylation was determined by western blot. Results: The eradication of a primary LLC-LM was followed by the rapid growth of pulmonary metastasis within 14 days after radiation. Radiation to the thigh tumor induced pulmonary metastasis significantly (Control vs. RT, p<0.001). Pulmonary metastases was significantly reduced with the addition of YC-1 to radiation (RT vs. RT+YC-1, p<0.001). YC-1 itself did not have any impact on pulmonary metastasis (Control vs. YC-1, p=0.883). The body weight of mice with radiation alone was lower than the other groups, but the difference was not statistically significant. The gelatin zymography with mouse urine samples showed that the level of MMP-2 activity, correlated with tumor growth, was much lower in YC-1 treated groups. The in vitro study showed YC-1 significantly inhibited radiation induced LLC-LM cell invasion on matrigel coated Boyden chamber, MMP-2 expression, and serum induced FAK phosphorylation.